In 2023, the global procalcitonin (PCT) assay market is expected to be worth USD 280.6 million. The market is expected to reach USD 512.9 million by 2033, expanding at a 6.2% CAGR throughout the forecast period. Due to the rising prevalence of sepsis and infectious diseases globally has heightened the demand for accurate and reliable diagnostic tools. PCT assays have emerged as valuable biomarkers for bacterial infections, enabling early detection and timely intervention, thereby improving patient outcomes.
The clinical utility of PCT as a biomarker for bacterial infections has gained recognition among healthcare professionals. PCT has demonstrated its value in differentiating bacterial from viral infections and assessing disease severity. This increased awareness and acceptance of PCT as a reliable indicator have led to its incorporation into clinical guidelines, further driving market growth.
Technological advancements in the field of diagnostic assays have positively impacted the PCT assay market. Innovations in immunoassay platforms, molecular diagnostics, and point-of-care testing have enhanced the sensitivity, specificity, and ease of use of PCT assays. These advancements have bolstered their adoption and expanded their applications in various healthcare settings.
In the time of antibiotic resistance, there is a growing emphasis on antibiotic stewardship programs. PCT assays play a vital role in guiding antibiotic therapy by aiding healthcare providers in making informed decisions about the initiation, duration, and discontinuation of antibiotic treatment. This focus on rational antibiotic use has significantly contributed to the adoption of PCT assays.
Key Takeaways from the Procalcitonin (PCT) Assay Market:
- The procalcitonin (PCT) assay market industry in the United States is predicted to reach USD 202.0 million by 2033, increasing at a 7.3% CAGR.
- The procalcitonin (PCT) assay market industry in the United Kingdom is estimated to reach a market size of USD 26.4 million, expanding at a CAGR of 8.3% by 2033.
- During the forecast period, the procalcitonin (PCT) assay market industry in China is expected to reach a market value of USD 62.7 million, securing an 9.1% CAGR.
- The procalcitonin (PCT) assay market industry in Japan is predicted to reach USD 20.8 million by 2033, increasing at a 6.7% CAGR.
- South Korea’s procalcitonin (PCT) assay market industry is predicted to achieve a market value of USD 13.9 million, rising at a 6.0% CAGR during the forecast period.
- With a CAGR of 8.0% from 2023 to 2033, the serum sample is expected to dominate the procalcitonin (PCT) assay market industry.
- With a CAGR of 6.5%, the test kits segment is expected to drive the global market throughout the forecast period.
- With a CAGR of 6.0%, the clinical use segment is anticipated to lead the global market during projected timeframe.
- With a CAGR of 7.2% from 2023 to 2033, the hospital is expected to dominate the procalcitonin (PCT) assay market industry.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
How Does the Competition Look in the Procalcitonin (PCT) Assay Market?
The procalcitonin (PCT) assay market sector is a very competitive one, with large firms fighting for market share. Several significant participants in this industry comprise are J. Mitra & Co. Pvt. Ltd., Thermo Fisher Scientific Inc., bioMérieux SA, Immuno-Biological Laboratories, Inc., and Roche Diagnostics among other companies. The major businesses are heavily spending in R&D efforts to create innovative and inventive goods with enhanced effectiveness, dependability, and affordability. They are also focusing on expanding their product line and strengthening their distribution methods in order to fulfil shifting consumer expectations.
Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another’s strengths and expand their market influence.
Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.
To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.
Key Developments in the Procalcitonin (PCT) Assay Market:
- In November 2020, Roche and bioMérieux announced a collaboration to improve antibiotic stewardship by developing and providing PCT assays on Roche’s cobas platforms.
- In February 2020, bioMérieux received FDA clearance for the Vidas BRAHMS PCT assay, which is an automated immunoassay platform for measuring PCT levels.
Segmentation Analysis of the Procalcitonin (PCT) Assay Market:
By Sample Type:
- Serum
- Plasma
- Cell Culture Medium
- Other Biological Fluids
By Product:
- Test Kits
- Procalcitonin ELISA test kits
- Procalcitonin CLIA kits
- PCT Immunochromatography KITS
- PCT Rapid Test Kit
- Analyzer & Instruments
- Consumables
By Purpose:
- Clinical Use
- Research Use Only
By End User:
- Hospital
- Specialty Clinics
- Academic and Research Institute
- Diagnostics Laboratories
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
